about
A systematic review and meta-regression of the prevalence and incidence of perinatal depression.The prevalence of depression and anxiety disorders in indigenous people of the Americas: A systematic review and meta-analysis.The oral health of people with anxiety and depressive disorders - a systematic review and meta-analysis.A systematic review and meta-analysis of the association between poor oral health and substance abuse.Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trialClozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis.Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-AnalysisClozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis.A systematic review and meta-analysis of the effects of Qigong and Tai Chi for depressive symptoms.The Mental Health of Older Persons After Human-Induced Disasters: A Systematic Review and Meta-Analysis of Epidemiological Data.Longitudinal comparative evaluation of the equivalence of an integrated peer-support and clinical staffing model for residential mental health rehabilitation: a mixed methods protocol incorporating multiple stakeholder perspectives.N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms.ECT efficacy and treatment course: a systematic review and meta-analysis of twice vs thrice weekly schedules.Planning estimates for the mental health community support sector.A domains-based taxonomy of supported accommodation for people with severe and persistent mental illness.System-level intersectoral linkages between the mental health and non-clinical support sectors: a qualitative systematic review.Deep brain stimulation for obsessive-compulsive disorder: a systematic review and meta-analysis.Getting started in research: research questions, supervisors and literature reviews.Getting started in research: systematic reviews and meta-analyses.A systematic review and meta-analysis of the association between poor oral health and severe mental illness.A systematic review and meta-analysis of the effect of depot antipsychotic frequency on compliance and outcome.Mental health implications for older adults after natural disasters--a systematic review and meta-analysis.The National Mental Health Commission Report: Evidence based or ideologically driven?Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.International trends in clozapine use: a study in 17 countries.Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes.Metabolic monitoring and management among clozapine users.People living with psychosocial disability: Rehabilitation and recovery-informed service provision within the second Australian national survey of psychosis.The impact of clozapine on hospital use: a systematic review and meta-analysis.Predictors of mental health-related acute service utilisation and treatment costs in the 12 months following an acute psychiatric admission.Motivational aftercare planning to better care: Applying the principles of advanced directives and motivational interviewing to discharge planning for people with mental illness.Mental health of young adult patients who do not attend appointments in primary care: a retrospective cohort study.Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?Further Reflections on Recovery-Oriented Mental Health Practice in a Community Care Unit.Increasing Clozapine Dispensing Trends in Queensland, Australia 2004-2013.Patterns of antipsychotic medication use in Australia 2002-2007.Anxiolytic, hypnotic and sedative medication use in Australia.Psychiatric drug prescribing in elderly Australians: time for action.Weight loss associated with exenatide in an obese man with diabetes commenced on clozapine.Clozapine in primary care.
P50
Q30234396-0B6A8338-EA52-47B7-97EA-6EE9E529C46DQ30244581-A8A2C25F-9521-4D32-BC3D-2763CF19E4D3Q30251464-8ED2BAF6-77EC-41D6-A58B-EF12DD936ACBQ30399977-940D54A4-6B5A-439D-8299-84F615B1674AQ30489980-A1C1F1B0-C0C6-40CF-94AD-877746715A4FQ31115350-CF14FE36-2313-429C-A703-6DBCF7B95197Q34530975-272AD1EB-2F46-45F1-AF16-0E4C5B3E2AB5Q34533333-5FE35C84-5172-4BD2-8901-765B67487647Q35746754-B5696AF8-EBF7-4638-8B71-A8085BC338AEQ35932067-769718B1-6D47-461A-BEA5-1F194646C25BQ36038773-D55750AB-44B2-45C8-94CB-C1BCAF23AE02Q36133400-8E9F593A-9AD8-497C-815F-8919B4675AC9Q37866475-FC9BC62E-3F06-4E70-A3C2-0CA73712AC65Q37996856-A71F2F61-130A-4C1B-B8EE-550BB22E702AQ38050937-C0029BD5-7332-47EA-B403-3CC327EC57A0Q38227160-797947BD-19BC-421C-8E3A-D55A6C81303EQ38234411-329C6322-1402-4A73-ABE2-5DF542446D37Q38260027-945668D2-6F78-47B1-B0F9-9E8853DEE78FQ38287664-7211907A-4DD4-463E-A925-067A068ECC9FQ38294857-686AFF78-B218-4379-8A7A-B8DEC6FED096Q38496721-1EFC9918-756B-4C9B-B16D-7A77B4880531Q38554643-F1D73097-F50E-49A2-A353-6D52B7CD202AQ38596919-DD7728B7-8BF3-4782-B950-7D1C2ACC9149Q38659786-2EE26816-C7F0-47FB-A5ED-4863F5D6D233Q38684191-6143AB9B-0CD0-49CB-B4BD-335B4AED3A5EQ38708352-C4C29D43-1494-4026-BC38-BADB4663D8F9Q38945107-2A64F68D-C224-47F3-BC05-18CF785ED8A7Q38953552-3BBD0832-8D9F-4381-80D7-379C904D865CQ39117168-40555EA5-F543-490C-9D48-387EF0E0D84CQ39158961-9FF741CE-5F17-42BC-B80D-306CD25E0FD4Q39343500-0C006FB0-0D30-4BCC-A3CF-18C74B66E02BQ39995881-F0A885FB-C3A4-49F6-A646-4491CDB6FBA6Q40105151-BAD00641-2244-45FD-9DF8-FBD9DBB16BE5Q40194474-7AD2618A-484E-49CA-9D70-B39CE9ACEB7BQ40820070-CA1378A0-B4D2-4F74-952F-A4515CAC003CQ43122181-9F153E39-7866-4487-9951-9ABA4D78D889Q43194874-EDC81F87-380D-4D0F-B395-F55F7F225F55Q44953288-340C31E2-899A-477F-9CC1-D5078E10DCB6Q47318274-32277191-0942-46EC-9E88-9DF41C73D988Q47551390-EDD316F1-8CCA-435A-9D2E-0032CE3D9BE5
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dan Siskind
@ast
Dan Siskind
@en
Dan Siskind
@es
Dan Siskind
@nl
Dan Siskind
@sl
type
label
Dan Siskind
@ast
Dan Siskind
@en
Dan Siskind
@es
Dan Siskind
@nl
Dan Siskind
@sl
prefLabel
Dan Siskind
@ast
Dan Siskind
@en
Dan Siskind
@es
Dan Siskind
@nl
Dan Siskind
@sl
P1053
A-9812-2014
P106
P21
P31
P3829
P496
0000-0002-2072-9216
P569
2000-01-01T00:00:00Z